Intraoperative Sufentanil and Chronic Postsurgical Pain in Non-major Scheduled Abdominal Surgery

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

855

Participants

Timeline

Start Date

March 17, 2024

Primary Completion Date

April 1, 2025

Study Completion Date

July 31, 2026

Conditions
Chronic Postsurgical PainChronic PainAbdominal SurgerySufentanilRisk Factors
Interventions
OTHER

phone interview

Patient's phone interview 3 months after operating room discharge. The interview consisting of 3 questionnaires to detect the presence of CPSP, its intensity, its characteristics and its related analgesic consumption.

Trial Locations (1)

80054

CHU Amiens-Picardie, Amiens

All Listed Sponsors
lead

Centre Hospitalier Universitaire, Amiens

OTHER

NCT06374849 - Intraoperative Sufentanil and Chronic Postsurgical Pain in Non-major Scheduled Abdominal Surgery | Biotech Hunter | Biotech Hunter